These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16039556)

  • 21. Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease.
    Garcia-Alloza M; Robbins EM; Zhang-Nunes SX; Purcell SM; Betensky RA; Raju S; Prada C; Greenberg SM; Bacskai BJ; Frosch MP
    Neurobiol Dis; 2006 Dec; 24(3):516-24. PubMed ID: 17029828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A nontransgenic mouse model shows inducible amyloid-beta (Abeta) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade.
    Dolev I; Michaelson DM
    Proc Natl Acad Sci U S A; 2004 Sep; 101(38):13909-14. PubMed ID: 15365176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contrasting in vivo effects of two peptide-based amyloid-beta protein aggregation inhibitors in a transgenic mouse model of amyloid deposition.
    Li Q; Gordon M; Etienne MA; Hammer RP; Morgan D
    Cell Transplant; 2008; 17(4):397-408. PubMed ID: 18522242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.
    Sipos E; Kurunczi A; Kasza A; Horváth J; Felszeghy K; Laroche S; Toldi J; Párducz A; Penke B; Penke Z
    Neuroscience; 2007 Jun; 147(1):28-36. PubMed ID: 17499931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Link between heart disease, cholesterol, and Alzheimer's disease: a review.
    Sparks DL; Martin TA; Gross DR; Hunsaker JC
    Microsc Res Tech; 2000 Aug; 50(4):287-90. PubMed ID: 10936882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template.
    Ha C; Ryu J; Park CB
    Biochemistry; 2007 May; 46(20):6118-25. PubMed ID: 17455909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease.
    Morgan D; Diamond DM; Gottschall PE; Ugen KE; Dickey C; Hardy J; Duff K; Jantzen P; DiCarlo G; Wilcock D; Connor K; Hatcher J; Hope C; Gordon M; Arendash GW
    Nature; 2000 Dec 21-28; 408(6815):982-5. PubMed ID: 11140686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A transgenic rat model of Alzheimer's disease with extracellular Abeta deposition.
    Flood DG; Lin YG; Lang DM; Trusko SP; Hirsch JD; Savage MJ; Scott RW; Howland DS
    Neurobiol Aging; 2009 Jul; 30(7):1078-90. PubMed ID: 18053619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease.
    Wyss-Coray T; Masliah E; Mallory M; McConlogue L; Johnson-Wood K; Lin C; Mucke L
    Nature; 1997 Oct; 389(6651):603-6. PubMed ID: 9335500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphatidylinositol and inositol involvement in Alzheimer amyloid-beta fibril growth and arrest.
    McLaurin J; Franklin T; Chakrabartty A; Fraser PE
    J Mol Biol; 1998 Apr; 278(1):183-94. PubMed ID: 9571042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Active immunization trial in Abeta42-injected P301L tau transgenic mice.
    Kulic L; Kurosinski P; Chen F; Tracy J; Mohajeri MH; Li H; Nitsch RM; Götz J
    Neurobiol Dis; 2006 Apr; 22(1):50-6. PubMed ID: 16289870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice.
    Kandimalla KK; Wengenack TM; Curran GL; Gilles EJ; Poduslo JF
    J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging distinct conformational states of amyloid-beta fibrils in Alzheimer's disease using novel luminescent probes.
    Nilsson KP; Aslund A; Berg I; Nyström S; Konradsson P; Herland A; Inganäs O; Stabo-Eeg F; Lindgren M; Westermark GT; Lannfelt L; Nilsson LN; Hammarström P
    ACS Chem Biol; 2007 Aug; 2(8):553-60. PubMed ID: 17672509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.
    Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P
    Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progranulin expression correlates with dense-core amyloid plaque burden in Alzheimer disease mouse models.
    Pereson S; Wils H; Kleinberger G; McGowan E; Vandewoestyne M; Van Broeck B; Joris G; Cuijt I; Deforce D; Hutton M; Van Broeckhoven C; Kumar-Singh S
    J Pathol; 2009 Oct; 219(2):173-81. PubMed ID: 19557827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo staining characteristics of small, fluorescent, Abeta42-binding D-enantiomeric peptides in transgenic AD mouse models.
    van Groen T; Kadish I; Wiesehan K; Funke SA; Willbold D
    ChemMedChem; 2009 Feb; 4(2):276-82. PubMed ID: 19072935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease.
    El Tannir El Tayara N; Delatour B; Le Cudennec C; Guégan M; Volk A; Dhenain M
    Neurobiol Dis; 2006 Apr; 22(1):199-208. PubMed ID: 16337798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropathology: Alzheimer's in real time.
    Masliah E
    Nature; 2008 Feb; 451(7179):638-9. PubMed ID: 18256653
    [No Abstract]   [Full Text] [Related]  

  • 39. Aurones serve as probes of beta-amyloid plaques in Alzheimer's disease.
    Ono M; Maya Y; Haratake M; Ito K; Mori H; Nakayama M
    Biochem Biophys Res Commun; 2007 Sep; 361(1):116-21. PubMed ID: 17644062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction of Alzheimer's disease amyloid plaque load in transgenic mice by D3, A D-enantiomeric peptide identified by mirror image phage display.
    van Groen T; Wiesehan K; Funke SA; Kadish I; Nagel-Steger L; Willbold D
    ChemMedChem; 2008 Dec; 3(12):1848-52. PubMed ID: 19016284
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.